نتائج البحث - "Sambevski, S."

1

Electronic Resource

Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease

المؤلفون: Allanore, Y., Khanna, D., Smith, V., Aringer, M., Hoffmann-Vold, A.M., Kuwana, M., Merkel, P.A., Stock, C., Vonk, M.C., Sambevski, S., Denton, C.P.

المصدر: Rheumatology, 63, 3, pp. 639-647

مصطلحات الفهرس: Radboudumc 5: Inflammatory diseases Rheumatology, Rheumatology - Radboud University Medical Center, Article / Letter to editor

URL: https://repository.ubn.ru.nl//bitstream/handle/2066/305344/305344.pdf
https://repository.ubn.ru.nl/handle/2066/305344

View record in OAIster

2

Academic Journal

OP0170 DECLINE IN FORCED VITAL CAPACITY (FVC) IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) WITH AND WITHOUT DYSPNOEA: DATA FROM THE SENSCIS TRIAL

المؤلفون: Volkmann, E., Kreuter, M., Hoffmann-Vold, A. M., Wijsenbeek, M., Smith, V., Khanna, D., Denton, C., Wuyts, W., Miede, C., Alves, M., Sambevski, S., Allanore, Y.

المصدر: Annals of the Rheumatic Diseases ; volume 80, issue Suppl 1, page 101.2-102 ; ISSN 0003-4967 1468-2060

الاتاحة: http://dx.doi.org/10.1136/annrheumdis-2021-eular.834
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2021-eular.834

View record in BASE

3

Conference

Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid decline in forced vital capacity: further analyses of the SENSCIS trial*

المؤلفون: Gläser, S, Khanna, D, Maher, T, Volkmann, E, Allanore, Y, Smith, V, Assassi, S, Kreuter, M, Hoffmann-Vold, A, Kuwana, M, Stock, C, Alves, M, Sambevski, S, Denton, C

المصدر: 63. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. ; Pneumologie ; ISSN 1438-8790

الاتاحة: http://dx.doi.org/10.1055/s-0043-1760999
http://www.thieme-connect.de/products/ejournals/html/10.1055/s-0043-1760999

View record in BASE

4

Conference

AB0270 DESIGN OF A PROSPECTIVE MULTI-NATIONAL CROSS-SECTIONAL STUDY ON SCREENING FOR INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) GUIDED BY RISK FACTORS

المؤلفون: Sparks, J., Dieudé, P., Hoffmann-Vold, A. M., Burmester, G. R., Walsh, S., Kreuter, M., Stock, C., Sambevski, S., Alves, M., Emery, P.

المصدر: Scientific Abstracts ; page 1316.1-1317

الاتاحة: http://dx.doi.org/10.1136/annrheumdis-2023-eular.2068
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2023-eular.2068

View record in BASE

5

Conference

Decline in forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) with and without cough: data from the SENSCIS trial*

المؤلفون: Kreuter, M, Volkmann, E R, Hoffmann-Vold, A, Wijsenbeek, M S, Smith, V, Khanna, D, Denton, C P, Wuyts, W A, Stock, C, Alves, M, Sambevski, S, Allanore, Y

المصدر: 62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. ; Pneumologie ; ISSN 1438-8790

الاتاحة: http://dx.doi.org/10.1055/s-0042-1747730
http://www.thieme-connect.de/products/ejournals/html/10.1055/s-0042-1747730

View record in BASE

6

Conference

Decline in forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) with and without dyspnoea: data from the SENSCIS trial*

المؤلفون: Kreuter, M, Volkmann, E R, Hoffmann-Vold, A, Wijsenbeek, M S, Smith, V, Khanna, D, Denton, C P, Wuyts, W A, Miede, C, Alves, M, Sambevski, S, Allanore, Y

المصدر: 62. Kongress der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e. V. ; Pneumologie ; ISSN 1438-8790

الاتاحة: http://dx.doi.org/10.1055/s-0042-1747731
http://www.thieme-connect.de/products/ejournals/html/10.1055/s-0042-1747731

View record in BASE

7

Academic Journal

P1879Empagliflozin reduces mortality and hospitalisation for heart failure irrespective of cardiovascular risk score at baseline

المؤلفون: Fitchett, D, Inzucchi, S E, Cannon, C P, McGuire, D K, Johansen, O E, Sambevski, S, Hehnke, U, George, J, Zinman, B

المصدر: European Heart Journal ; volume 39, issue suppl_1 ; ISSN 0195-668X 1522-9645

الاتاحة: https://doi.org/10.1093/eurheartj/ehy565.p1879
http://academic.oup.com/eurheartj/article-pdf/39/suppl_1/ehy565.P1879/25577685/ehy565.p1879.pdf

View record in BASE

8

Academic Journal

OP0157 EFFECT OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSc-ILD) AND RISK FACTORS FOR RAPID DECLINE IN FORCED VITAL CAPACITY: FURTHER ANALYSES OF THE SENSCIS TRIAL

المؤلفون: Khanna, D., Maher, T., Volkmann, E., Allanore, Y., Smith, V., Assassi, S., Kreuter, M., Hoffmann-Vold, A. M., Kuwana, M., Stock, C., Alves, M., Sambevski, S., Denton, C. P.

المصدر: Annals of the Rheumatic Diseases ; volume 81, issue Suppl 1, page 102-103 ; ISSN 0003-4967 1468-2060

الاتاحة: http://dx.doi.org/10.1136/annrheumdis-2022-eular.769
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.769

View record in BASE

9

Academic Journal

POS0070 CONTINUED TREATMENT WITH NINTEDANIB IN PATIENTS WITH LIMITED CUTANEOUS SYSTEMIC SCLEROSIS (lcSSc) AND INTERSTITIAL LUNG DISEASE (ILD)

المؤلفون: Allanore, Y., Khanna, D., Smith, V., Aringer, M., Hoffmann-Vold, A. M., Kuwana, M., Merkel, P. A., James, A., Sambevski, S., Alves, M., Denton, C. P.

المصدر: Annals of the Rheumatic Diseases ; volume 81, issue Suppl 1, page 251.2-252 ; ISSN 0003-4967 1468-2060

الاتاحة: http://dx.doi.org/10.1136/annrheumdis-2022-eular.754
https://syndication.highwire.org/content/doi/10.1136/annrheumdis-2022-eular.754

View record in BASE

10

Conference

Empagliflozin reduces mortality and hospitalisation for heart failure in patients with or without a history of myocardial infarction or stroke at baseline

المؤلفون: Sambevski, S, Fitchett, D, Inzucchi, S, Kaspers, S, Pfarr, E, George, J, Zinman, B

المصدر: Diabetes – Nicht nur eine Typ-Frage – www.diabeteskongress.de ; Diabetologie und Stoffwechsel ; ISSN 1861-9010

الاتاحة: http://dx.doi.org/10.1055/s-0039-1688297
http://www.thieme-connect.de/products/ejournals/html/10.1055/s-0039-1688297

View record in BASE

11

Academic Journal

Empagliflozin selected cardiovascular and safety outcomes in routine care: First results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study

المؤلفون: Patorno, E., Pawar, A., Franklin, J.M., Najafzadeh, M., Déruaz-Luyet, A., Brodovicz, K.G., Sambevski, S., Bessette, L.G., Kulldorff, M., Schneeweiss, S.

المصدر: Metabolism ; volume 104, page 154126 ; ISSN 0026-0495

الاتاحة: http://dx.doi.org/10.1016/j.metabol.2019.12.072
https://api.elsevier.com/content/article/PII:S0026049519303397?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0026049519303397?httpAccept=text/plain

View record in BASE

12

Academic Journal

EMPAGLIFLOZIN REDUCES MORTALITY AND HOSPITALIZATION FOR HEART FAILURE IN PATIENTS WITH OR WITHOUT A HISTORY OF MYOCARDIAL INFARCTION OR STROKE AT BASELINE

المؤلفون: Fitchett, D., Inzucchi, S., Sambevski, S., Kaspers, S., Pfarr, E., George, J., Zinman, B.

المصدر: Canadian Journal of Cardiology ; volume 34, issue 10, page S80-S81 ; ISSN 0828-282X

الاتاحة: http://dx.doi.org/10.1016/j.cjca.2018.07.288
https://api.elsevier.com/content/article/PII:S0828282X18308043?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0828282X18308043?httpAccept=text/plain

View record in BASE

13

Academic Journal

DESIGN OF A PROSPECTIVE MULTI-NATIONAL CROSS-SECTIONAL STUDY ON SCREENING FOR INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA) GUIDED BY RISK FACTORS.

المؤلفون: Sparks, J., Dieudé, P., Hoffmann-Vold, A. M., Burmester, G. R., Walsh, S., Kreuter, M., Stock, C., Sambevski, S., Alves, M., Emery, P.

المصدر: Annals of the Rheumatic Diseases; 2023 Supplement, Vol. 82, p1316-1317, 2p

تنقيح النتائج